Varun Kumar, MD
- Castle Connolly Top Doctor: 2021, 2022, 2023, 2024
- Hudson Valley Magazine Top Doctor: 2021-2024
- Dutchess County Regional Chamber of Commerce Forty Under 40 Mover & Shaker Award: 2019
- Chief Medical Resident - Yale New Haven Hospital: 2014
- Gold Humanism Honor Society - Yale New Haven Hospital: 2013
- Magna Cum Laude - Fordham University: 2006
- Phi Beta Kappa - Fordham University: 2006
- Fordham Club Honor Society - Fordham University: 2006
- Undergraduate & Graduate
- Fordham University: 2006
- Medical Education
- Stony Brook University: 2010
- Residency
- Yale-New Haven Hospital: 2013 Yale-New Haven Hospital, Chief Resident: 2014
- Fellowship
- Yale School of Medicine: 2017
- Board Certifications
- American Board of Internal Medicine: 2013
- American Board of Gastroenterology: 2017
- Vassar Brothers Medical Center
- Mid Hudson Regional Hospital of Westchester Medical Center
- Kumar, V., Grant, T., Nagar, A. (2013) Adherence to Quality of Care Measures in Patients with Inflammatory Bowel Disease May Not Improve Patient Outcomes. Digestive Disease Week. Orlando, FL 2013
- Kumar, V. (2013). Acute Diarrhea. In Yale Office-based Medicine Curriculum, eds. Julie R Rosenbaum, Seonaid Hay, Laura Whitman, and Mary Warner, 8th edition. New Haven, CT: Yale University
- Kumar, V., Chaptini, L., (2013). Acute Lower G.I. Bleed. In Yale Inpatient Medicine Curriculum, editor Dana Dunne. New Haven, CT: Yale University
- Mansoor S., Kumar, V., Aslanian, H., (2015). Stercoral Colitis. American Journal of Gastroenterology. Image of the month. Dec;110(12):1651
- Mansoor MS., Kumar V., Feuerstadt, P. Men with CDI Have Increased Co-Morbidities and Worsened Long-Term Outcome Compared with Women. Digestive Disease Week, San Diego, CA 2016
- Zhou, E., Kumar, V., Mansoor, MS., Feuerstadt, P. Pseudomembranes Are Infrequently Seen in Patients Undergoing Fecal Microbiota Transplant (FMT) for Recurrent C. difficile Infection (CDI) . ACG, Las Vegas 2016
- Kumar, V., Zhou, E., Mansoor, MS., Feuerstadt, P. Treatment of Initial Recurrence of C. Difficile Infection (CDI) with Vancomycin May Not Prevent Eventual Need for Fecal Microbial Transplantation (FMT). ACG, Las Vegas 2016
- Afinogenova, Y., Kumar, V., Mansoor, MS., Feuerstadt, P. 5-Aminosalicylic Acid (5-ASA) Usage During C. Difficile Infection (CDI) is Associated with Decreased ICU Admission and Improved Long-Term Outcomes. ACG, Las Vegas 201
- Viera, S., Kumar, V., Kriegel, M. A Gut Commensal Breaches Both Gut Lymphatic and Vascular Barriers to Drive Systemic Autoimmunity. Keystone Symposia: Microbiome in Health and Disease. Colorado, 2017
- Kumar V, Zhou E, Afinogenova Y, Mansoor S, Sharma P and Feuerstadt P. Serum Derived Bovine Immunoglobulin (SBI) is Safe and Well Tolerated in Patients Undergoing Fecal Microbiota Transplant (FMT) for Recurrent C. difficile Infection (RCDI). ACG, Orlando 2017
- Zhou E, Kumar V, Afinogenova Y, Mansoor S, Sharma P and Feuerstadt P. Serum Derived Bovine Immunoglobulin (EnteraGam, SBI) is Safe and Well Tolerated in Patients Undergoing Fecal Microbiota Transplant (FMT) for Recurrent C. difficile Infection (RCDI). ACG, Orlando 2017
- Sharma P, Kumar V, Mansoor S, Feuerstadt P. Recurrence of C. difficile Infection (CDI) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Treated With Metronidazole, Vancomycin or Combination Therapy. ACG, Orlando 2017
- Viera, S., M. Hiltensperger., Kumar, V., Kriegel, M. Spontaneous Translocation of a Gut Pathobiont Drives Autoimmunity that is Preventable by Vaccination - March 2018. Science